Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 22Breast Neoplasms 21Neoplasms 10Brain Neoplasms 10Glioma 8Head and Neck Neoplasms 7Lymphoma 6Colonic Neoplasms 6Urinary Bladder Neoplasms 5Rectal Neoplasms 5Pancreatic Neoplasms 5Lymphoma, Non-Hodgkin 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Glioblastoma 4Carcinoma, Hepatocellular 4Astrocytoma 4Squamous Cell Carcinoma of Head and Neck 3Spinal Cord Neoplasms 3Lung Neoplasms 3Stomach Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Oligodendroglioma 2Neurofibromatosis 1 2Neoplasm Metastasis 2Multiple Myeloma 2Meningioma 2Lymphoma, B-Cell 2Liver Neoplasms 2

Interventions

fludarabine phosphate 1fludarabine 1artesunic acid 1artenimol 1artemisinin 1aldesleukin 1Respiratory Function Tests 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Meperidine 1Magnetic Resonance Imaging 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Hydroxyzine 1Granisetron 1Electrocardiography 1Droperidol 1Doxylamine 1Diphenoxylate 1Diphenhydramine 1Cyclophosphamide 1Codeine 1Cell Count 1Biopsy 1Atropine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Vulvar Diseases × Magnetic Resonance Imaging × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡